MedPath

Effect of 0.9% NaCl on incidence of hyperchloremic metabolic acidosis

Phase 3
Completed
Conditions
eurosurgical patients
crystalloid
hyperchloremic metabolic acidosis
Registration Number
TCTR20200703004
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
28
Inclusion Criteria

patient aged 18-65 year old
ASA 1-3
Craniotomy for tumor removal

Exclusion Criteria

Recieve diuretics
diabetic insipidus
SIADH
emergency surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of hyperchloremic metabolic acidosis 1 hr and 1 day post operative period percentage
Secondary Outcome Measures
NameTimeMethod
electrolyte profile 1 hr and 1 day post operative period Electrolyte concentration
© Copyright 2025. All Rights Reserved by MedPath